Literature DB >> 12736319

The (52-96) C-terminal domain of Vpr stimulates HIV-1 IN-mediated homologous strand transfer of mini-viral DNA.

Julien Bischerour1, Patrick Tauc, Hervé Leh, Hugues de Rocquigny, Bernard Roques, Jean-François Mouscadet.   

Abstract

Viral integrase (IN) and Vpr are both components of the human immunodeficiency virus type 1 (HIV-1) pre-integration complex. To investigate whether these proteins interact within this complex, we investigated the effects of Vpr and its subdomains on IN activity in vitro. When a 21mer oligonucleotide was used as a donor and acceptor, both Vpr and its C-terminal DNA-binding domain [(52-96)Vpr] inhibited the integration reaction, whereas the (1-51)Vpr domain did not affect IN activity. Steady-state fluorescence anisotropy showed that both full-length and (52-96)Vpr bind to the short oligonucleotide, thereby extending previous observations with long DNA. The concentrations of the two proteins required to inhibit IN activity were consistent with their affinities for the oligonucleotide. The use of a 492 bp mini-viral substrate confirmed that Vpr can inhibit the IN-mediated reaction. However, the activity of (52-96)Vpr differed notably since it stimulated specifically integration events involving two homologous mini-viral DNAs. Order of addition experiments indicated that the stimulation was maximal when IN, (50-96)Vpr and the mini-viral DNA were allowed to form a complex. Furthermore, in the presence of (50-96)Vpr, the binding of IN to the mini-viral DNA was dramatically enhanced. Taken together, these data suggest that (52-96)Vpr stimulates the formation of a specific complex between IN and the mini-viral DNA.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12736319      PMCID: PMC156046          DOI: 10.1093/nar/gkg364

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  43 in total

1.  Efficient DNA transfection mediated by the C-terminal domain of human immunodeficiency virus type 1 viral protein R.

Authors:  A Kichler; J C Pages; C Leborgne; S Druillennec; C Lenoir; D Coulaud; E Delain; E Le Cam; B P Roques; O Danos
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  Interactions of the C-terminus of viral protein R with nucleic acids are modulated by its N-terminus.

Authors:  H de Rocquigny; A Caneparo; T Delaunay; J Bischerour; J F Mouscadet; B P Roques
Journal:  Eur J Biochem       Date:  2000-06

3.  Disruption of HIV-1 integrase-DNA complexes by short 6-oxocytosine-containing oligonucleotides.

Authors:  Priscille Brodin; Marina Pinskaya; Malcolm Buckle; Uwe Parsch; Elena Romanova; Joachim Engels; Marina Gottikh; Jean-François Mouscadet
Journal:  Biochemistry       Date:  2002-02-05       Impact factor: 3.162

4.  Identification of HIV-1 vpr product and function.

Authors:  E A Cohen; E F Terwilliger; Y Jalinoos; J Proulx; J G Sodroski; W A Haseltine
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

5.  Retroviral integration: structure of the initial covalent product and its precursor, and a role for the viral IN protein.

Authors:  P O Brown; B Bowerman; H E Varmus; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

6.  Efficient concerted integration by recombinant human immunodeficiency virus type 1 integrase without cellular or viral cofactors.

Authors:  Sapna Sinha; Michael H Pursley; Duane P Grandgenett
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

7.  Phosphorylation of Vpr regulates HIV type 1 nuclear import and macrophage infection.

Authors:  Isabelle Agostini; Serguei Popov; Tang Hao; Jian Hua Li; Larisa Dubrovsky; Oleg Chaika; Nina Chaika; Robert Lewis; Michael Bukrinsky
Journal:  AIDS Res Hum Retroviruses       Date:  2002-03-01       Impact factor: 2.205

8.  Cellular distribution and karyophilic properties of matrix, integrase, and Vpr proteins from the human and simian immunodeficiency viruses.

Authors:  C Depienne; P Roques; C Créminon; L Fritsch; R Casseron; D Dormont; C Dargemont; S Benichou
Journal:  Exp Cell Res       Date:  2000-11-01       Impact factor: 3.905

9.  Retroviral DNA integration: structure of an integration intermediate.

Authors:  T Fujiwara; K Mizuuchi
Journal:  Cell       Date:  1988-08-12       Impact factor: 41.582

10.  NMR structure of the HIV-1 regulatory protein Vpr in H2O/trifluoroethanol. Comparison with the Vpr N-terminal (1-51) and C-terminal (52-96) domains.

Authors:  K Wecker; N Morellet; S Bouaziz; B P Roques
Journal:  Eur J Biochem       Date:  2002-08
View more
  13 in total

Review 1.  HIV integrase inhibitors: 20-year landmark and challenges.

Authors:  Mathieu Métifiot; Christophe Marchand; Yves Pommier
Journal:  Adv Pharmacol       Date:  2013

Review 2.  HIV Genome-Wide Protein Associations: a Review of 30 Years of Research.

Authors:  Guangdi Li; Erik De Clercq
Journal:  Microbiol Mol Biol Rev       Date:  2016-06-29       Impact factor: 11.056

3.  Peptide HIV-1 integrase inhibitors from HIV-1 gene products.

Authors:  Shintaro Suzuki; Emiko Urano; Chie Hashimoto; Hiroshi Tsutsumi; Toru Nakahara; Tomohiro Tanaka; Yuta Nakanishi; Kasthuraiah Maddali; Yan Han; Makiko Hamatake; Kosuke Miyauchi; Yves Pommier; John A Beutler; Wataru Sugiura; Hideyoshi Fuji; Tyuji Hoshino; Kyoko Itotani; Wataru Nomura; Tetsuo Narumi; Naoki Yamamoto; Jun A Komano; Hirokazu Tamamura
Journal:  J Med Chem       Date:  2010-07-22       Impact factor: 7.446

4.  A protein ballet around the viral genome orchestrated by HIV-1 reverse transcriptase leads to an architectural switch: from nucleocapsid-condensed RNA to Vpr-bridged DNA.

Authors:  Sébastien Lyonnais; Robert J Gorelick; Fatima Heniche-Boukhalfa; Serge Bouaziz; Vincent Parissi; Jean-François Mouscadet; Tobias Restle; Jose Maria Gatell; Eric Le Cam; Gilles Mirambeau
Journal:  Virus Res       Date:  2012-09-24       Impact factor: 3.303

5.  Measuring rapid hydrogen exchange in the homodimeric 36 kDa HIV-1 integrase catalytic core domain.

Authors:  Nicholas C Fitzkee; Dennis A Torchia; Ad Bax
Journal:  Protein Sci       Date:  2011-02-17       Impact factor: 6.725

6.  The C-terminal domain of the HIV-1 regulatory protein Vpr adopts an antiparallel dimeric structure in solution via its leucine-zipper-like domain.

Authors:  Sarah Bourbigot; Hervé Beltz; Jérôme Denis; Nelly Morellet; Bernard P Roques; Yves Mély; Serge Bouaziz
Journal:  Biochem J       Date:  2005-04-15       Impact factor: 3.857

7.  Cell-permeable stapled peptides based on HIV-1 integrase inhibitors derived from HIV-1 gene products.

Authors:  Wataru Nomura; Haruo Aikawa; Nami Ohashi; Emiko Urano; Mathieu Métifiot; Masayuki Fujino; Kasthuraiah Maddali; Taro Ozaki; Ami Nozue; Tetsuo Narumi; Chie Hashimoto; Tomohiro Tanaka; Yves Pommier; Naoki Yamamoto; Jun A Komano; Tsutomu Murakami; Hirokazu Tamamura
Journal:  ACS Chem Biol       Date:  2013-08-15       Impact factor: 5.100

8.  Defining the DNA substrate binding sites on HIV-1 integrase.

Authors:  James Dolan; Aiping Chen; Irene T Weber; Robert W Harrison; Jonathan Leis
Journal:  J Mol Biol       Date:  2008-11-07       Impact factor: 5.469

Review 9.  HIV-1 IN inhibitors: 2010 update and perspectives.

Authors:  Christophe Marchand; Kasthuraiah Maddali; Mathieu Métifiot; Yves Pommier
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

10.  The host-pathogen interaction of human cyclophilin A and HIV-1 Vpr requires specific N-terminal and novel C-terminal domains.

Authors:  Sara M Ø Solbak; Victor Wray; Ole Horvli; Arnt J Raae; Marte I Flydal; Petra Henklein; Peter Henklein; Manfred Nimtz; Ulrich Schubert; Torgils Fossen
Journal:  BMC Struct Biol       Date:  2011-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.